Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 122.0 | 49 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 104.0 | 46 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 48.5 | 46 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MCP3 | 80.0 | 39 | |
0 | MCP3 | 17.0 | 60 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 49.0 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 44.0 | 57 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 26.5 | 68 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 38.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 34.0 | 75 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 32.0 | 63 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 171.0 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 201.0 | 60 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 135.5 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 142.5 | 60 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 61.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP3 | 102.0 | 59 | |
RA2159 | 3 | MCP3 | 0 | ||||||||
RA2159 | PD184352 | 0.1 | uM | 3 | MCP3 | 0 | |||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | MCP3 | 0 | |||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | MCP3 | 0 | |||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | MCP3 | 0 | |||||
RA2159 | IKK16 | 2.0 | uM | 3 | MCP3 | 0 | |||||
RA2159 | 3 | MCP3 | 0 | ||||||||
N2586 | 3 | MCP3 | 0 |